BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23883243)

  • 1. Cystic renal cell carcinomas: do they grow, metastasize, or recur?
    Jhaveri K; Gupta P; Elmi A; Flor L; Moshonov H; Evans A; Jewett M
    AJR Am J Roentgenol; 2013 Aug; 201(2):W292-6. PubMed ID: 23883243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic outcomes of cystic renal cell carcinoma.
    Donin NM; Mohan S; Pham H; Chandarana H; Doshi A; Deng FM; Stifelman MD; Taneja SS; Huang WC
    Clin Genitourin Cancer; 2015 Feb; 13(1):67-70. PubMed ID: 25088469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
    Doshi AM; Huang WC; Donin NM; Chandarana H
    AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
    Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
    AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.
    Guo J; Tretiakova MS; Troxell ML; Osunkoya AO; Fadare O; Sangoi AR; Shen SS; Lopez-Beltran A; Mehra R; Heider A; Higgins JP; Harik LR; Leroy X; Gill AJ; Trpkov K; Campbell SC; Przybycin C; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2014 Nov; 38(11):1457-67. PubMed ID: 25093518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
    Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
    Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
    Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
    AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
    Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
    Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
    Egbert ND; Caoili EM; Cohan RH; Davenport MS; Francis IR; Kunju LP; Ellis JH
    AJR Am J Roentgenol; 2013 Aug; 201(2):347-55. PubMed ID: 23883215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating radiological features of rapid- and slow-growing renal cell carcinoma using multidetector computed tomography.
    Choi SJ; Kim HS; Ahn SJ; Park Y; Choi HY
    J Comput Assist Tomogr; 2012; 36(3):313-8. PubMed ID: 22592616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplification of the Fuhrman grading system for renal cell carcinoma.
    Smith ZL; Pietzak EJ; Meise CK; Van Arsdalen K; Wein AJ; Malkowicz SB; Guzzo TJ
    Can J Urol; 2015 Dec; 22(6):8069-73. PubMed ID: 26688135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.